Zhejiang Jolly Pharmaceutical Co.,LTD

XSEC:300181 주식 보고서

시가총액: CN¥10.9b

Zhejiang Jolly PharmaceuticalLTD 미래 성장

Future 기준 확인 5/6

Zhejiang Jolly PharmaceuticalLTD is forecast to grow earnings and revenue by 24.6% and 23.9% per annum respectively. EPS is expected to grow by 24.3% per annum. Return on equity is forecast to be 23.3% in 3 years.

주요 정보

24.6%

수익 성장률

24.3%

EPS 성장률

Pharmaceuticals 수익 성장19.3%
매출 성장률23.9%
향후 자기자본 수익률23.3%
애널리스트 커버리지

Low

마지막 업데이트28 Oct 2024

최근 미래 성장 업데이트

업데이트 없음

Recent updates

수익 및 매출 성장 예측

XSEC:300181 - 애널리스트의 미래 추정치 및 과거 재무 데이터 (CNY Millions )
날짜수익수익잉여 현금 흐름작전 현금평균 애널리스트 수
12/31/20264,231885N/A8821
12/31/20253,333688N/A7061
12/31/20242,641547N/A6711
9/30/20242,522518116279N/A
6/30/20242,359481245381N/A
3/31/20242,120428145294N/A
12/31/20231,942383157288N/A
9/30/20231,926356162349N/A
6/30/20231,922336137310N/A
3/31/20231,86130291245N/A
1/1/20231,805273141319N/A
9/30/20221,72325258260N/A
6/30/20221,65522875290N/A
3/31/20221,55720474290N/A
1/1/20221,457179104252N/A
9/30/20211,400158234319N/A
6/30/20211,322145269336N/A
3/31/20211,238122267327N/A
12/31/20201,09189221280N/A
9/30/20201,02449180222N/A
6/30/20209492982118N/A
3/31/202090126112148N/A
12/31/20199112688129N/A
9/30/201985934109160N/A
6/30/20197671439131N/A
3/31/201976423-5104N/A
12/31/201873021-7678N/A
9/30/201860920-12536N/A
6/30/201862931N/A102N/A
3/31/201864743N/A20N/A
12/31/201767945N/A8N/A
9/30/201780449N/A114N/A
6/30/201781463N/A21N/A
3/31/201783059N/A54N/A
12/31/201684072N/A58N/A
9/30/201681986N/A22N/A
6/30/201681087N/A78N/A
3/31/201672085N/A112N/A
12/31/201567185N/A97N/A
9/30/2015657103N/A16N/A
6/30/2015620111N/A-18N/A
3/31/2015572107N/A-39N/A
12/31/2014515103N/A14N/A
9/30/201445794N/A13N/A
6/30/201444090N/A35N/A
3/31/201443185N/A42N/A
12/31/201341981N/A30N/A

애널리스트 미래 성장 예측

수입 대 저축률: 300181's forecast earnings growth (24.6% per year) is above the savings rate (2.9%).

수익 vs 시장: 300181's earnings (24.6% per year) are forecast to grow slower than the CN market (25.8% per year).

고성장 수익: 300181's earnings are expected to grow significantly over the next 3 years.

수익 대 시장: 300181's revenue (23.9% per year) is forecast to grow faster than the CN market (14% per year).

고성장 수익: 300181's revenue (23.9% per year) is forecast to grow faster than 20% per year.

주당 순이익 성장 예측

미래 자기자본 수익률

미래 ROE: 300181's Return on Equity is forecast to be high in 3 years time (23.3%)

성장 기업 발견

7D

1Y

7D

1Y

7D

1Y